论文部分内容阅读
将 1 8 4例吸入性变应原皮试阳性的哮喘患者随机分为两组 ,治疗组 ( A组 ) 92例在常规治疗的基础上加用变应原浸液进行特异性免疫治疗 ( SIT) ;对照组 ( B组 ) 92例采用常规治疗 ,并在治疗前后进行肺功能测定。结果 :治疗组中显效 2 8例 ,有效 48例 ,无效 1 6例 ,总有效率为 82 .61 %。对照组中显效 1 2例 ,有效 38例 ,无效 44例 ,总有效率为 5 4 .35 %。治疗组明显优于对照组 ( P<0 .0 5 )。提示 :应用相应的变应原进行 SIT治疗 ,安全有效 ,其疗程与疗效成正比
A total of 184 asthmatic patients with inhaled allergen skin test were randomly divided into two groups: group A (n = 92) received conventional immunotherapy (SIT) with allergen infusion on the basis of routine treatment, ; Control group (group B) 92 cases of conventional treatment, and lung function tests before and after treatment. Results: In the treatment group, 28 cases were markedly effective, 48 cases were effective and 16 cases were ineffective. The total effective rate was 82.61%. In the control group, 12 cases were markedly effective, 38 cases were effective and 44 cases were ineffective. The total effective rate was 54.35%. The treatment group was significantly better than the control group (P <0.05). Tip: The application of the corresponding allergen SIT treatment, safe and effective, and its course of treatment is proportional to the effect